• Array BioPharma collaborates with Pfizer biospectrumasia
    November 19, 2018
    Novel combinations of binimetinib (MEK), avelumab (PD-L1), and talazoparib (PARP inhibitor) to be studied across tumor types
PharmaSources Customer Service